Kubota Pharmaceutical Holdings Co., Ltd.

2026/11/20 20:23 Updated
Market Cap: $51.1M (¥8.1B)
Stock Price: $0.32 (¥50)
Exchange Rate: 1 USD = ¥158.73

Notice Regarding Large-Scale Exercise of the 41st Stock Acquisition Rights Issued by Third-Party Allotment (with Exercise Price Adjustment Clause)

Large-scale exercise of stock acquisition rights occurred. Number of shares delivered is 2,020,000 shares, exercise ratio is 10.1% (against total issued units of 200,000). Between November 11 and November 20 within the period from November 10 to 20, approximately 1,540,700 shares were confirmed exercised, resulting in transferred treasury stock. Outstanding unexercised stock acquisition rights remain at 179,800 units (17,980,000 shares).

Importance:
Page Updated: November 20, 2026
IR Disclosure Date: November 20, 2026

Key Figures

  • Number of shares delivered: 2,020,000 shares
  • Exercise ratio: 10.1%
  • Total shares outstanding (as of 11/09): 162,144,288 shares

AI要約

Overview

Kubota Pharmaceutical Holdings Co., Ltd. announced a large-scale exercise of stock acquisition rights issued by third-party allotment. The relevant rights are the 41st series (with an exercise price adjustment clause). From November 10, 2026, the number of shares to be delivered is 2,020,000 shares, and the exercise ratio versus total issued units of 200,000 is 10.1%. Exercise activity from November 10 showed multiple large-scale exercises between November 11 and November 20, with a total of approximately 2,640,000 units exercised. Currently, unexercised stock acquisition rights total 179,800 units (17,980,000 shares) and are recorded as transferred treasury stock. Total shares outstanding are 162,144,288 shares (including 187 treasury shares).

Impact and Outlook

Share transfers resulting from the exercise of stock acquisition rights should be considered for potential dilution. However, this document does not provide specific post-exercise financial figures; it only states the remaining unexercised rights. Depending on future exercise activity, shareholder composition and the degree of dilution may change, making additional disclosures important for investment decisions. Further explanation within disclosures is needed to assess accounting impacts and effects on dividend capacity.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Kubota Pharmaceutical Holdings Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →